Sunday, October 23, 2016

ZoDERM





Dosage Form: emulsion
ZoDERM®

(5.75% Benzoyl Peroxide)

Hydrating

Wash™

Benzoyl Peroxide in a Urea Vehicle

Rx Only



DESCRIPTION:


ZoDERM® 5.75% Benzoyl Peroxide HYDRATING WASH™ is intended for topical administration and contains Benzoyl Peroxide for use in the treatment of acne vulgaris. Benzoyl Peroxide is an oxidizing agent that possesses antibacterial properties and is classified as a keratolytic. Benzoyl Peroxide (Cl4H10O4) is represented by the following chemical structure:



Each mL of ZoDERM® 5.75% Benzoyl Peroxide HYDRATING WASH™ contains 57.5 mg of benzoyl peroxide in an emulsion-based formulation consisting of: purified water, urea (10%), sodium lauryl sulfoacetate, glycerin, propylene glycol, magnesium aluminum silicate, disodium oleamido MEA-sulfosuccinate, sodium octoxynol-2 ethane sulfonate, cetyl alcohol, laureth-12, glyceryl stearate/PEG-100 stearate, xanthan gum, citric acid, sodium citrate, carbomer and disodium EDTA.



CLINICAL PHARMACOLOGY:


The mechanism of action of Benzoyl Peroxide is not totally understood but its antibacterial activity against Propionibacterium acnes is thought to be a major mode of action. In addition, patients treated with Benzoyl Peroxide show a reduction in lipids and free fatty acids, and mild desquamation (drying and peeling activity) with simultaneous reduction in comedones and acne lesions.


Little is known about the percutaneous penetration, metabolism, and excretion of Benzoyl Peroxide, although it has been shown that Benzoyl Peroxide absorbed by the skin is metabolized to benzoic acid and then excreted as benzoate in the urine. There is no evidence of systemic toxicity caused by Benzoyl Peroxide in humans.



INDICATIONS AND USAGE:


ZoDERM® 5.75% Benzoyl Peroxide HYDRATING WASH™ is indicated for the topical treatment of acne vulgaris.



CONTRAINDICATIONS:


This preparation is contraindicated in patients with a history of hypersensitivity to any of its components.



WARNINGS:


When using this product, avoid unnecessary sun exposure and use a sunscreen.



PRECAUTIONS:



General: For external use only. If severe irritation develops, discontinue use and institute appropriate therapy. After reaction clears, treatment may often be resumed with less frequent application. These preparations should not be used in or near the eyes or on mucous membranes.



Information for Patients: Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. Contact with any colored material (including hair and fabric) may result in bleaching or discoloration. If excessive irritation develops, discontinue use and consult your physician.



Carcinogenesis, Mutagenesis, Impairment of Fertility: Data from several studies employing a strain of mice that is highly susceptible to developing cancer suggest that Benzoyl Peroxide acts as a tumor promoter. The clinical significance of these findings to humans is unknown. Benzoyl Peroxide has not been found to be mutagenic (Ames Test) and there are no published data indicating it impairs fertility.



Pregnancy: Teratogenic Effects: Pregnancy Category C: Animal reproduction studies have not been conducted with Benzoyl Peroxide. It is not known whether Benzoyl Peroxide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Benzoyl Peroxide should be used by a pregnant woman only if clearly needed. There are no available data on the effect of Benzoyl Peroxide on the later growth, development and functional maturation of the unborn child.



Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Benzoyl Peroxide is administered to a nursing woman.



Pediatric Use: Safety and effectiveness in children have not been established.



ADVERSE REACTIONS:


Allergic contact dermatitis and dryness have been reported with topical Benzoyl Peroxide therapy.


OVERDOSAGE: If excessive scaling, erythema or edema occurs, the use of this preparation should be discontinued. To hasten resolution of the adverse effects, cool compresses may be used. After symptoms and signs subside, a reduced dosage schedule may be cautiously tried if the reaction is judged to be due to excessive use and not allergenicity.



DOSAGE AND ADMINISTRATION:


ZoDERM® 5.75% Benzoyl Peroxide HYDRATING WASH™: Wash affected areas once or twice a day, or as directed by your dermatologist. Wet skin and liberally apply to areas to be cleansed, massage gently into skin for 10-20 seconds, working into a full lather, rinse thoroughly and pat dry. If excessive drying occurs, it may be controlled by rinsing off hydrating wash sooner or using less often.



HOW SUPPLIED:


ZoDERM® 5.75% Benzoyl Peroxide HYDRATING WASH™ is supplied in 473 mL bottles, NDC 10337-758-51.


Store at controlled room temperature 15°-25° C (59°-77° F). Protect from freezing.


KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.


Patent Pending


Manufactured for:


DERM/arts DIVISION

DOAK DERMATOLOGICS

A SUBSIDIARY OF BRADLEY PHARMACEUTICALS, INC.

383 Route 46 West

Fairfield, NJ 07004-2402 USA

www.doakderm.com


Manufactured by: Groupe PARIMA, Inc.

Montreal, QC H4S 1X6 CANADA


IL373


lss.10/07


PharmaDerm®

A division of Nycomed US Inc.

©2008 PharmaDerm, Melville, NY 11747.


All rights reserved.

98NZC010308



PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 473 ML LABEL


NDC 10337-758-51


Rx only


ZoDERM®


(5.75% Benzoyl Peroxide)


HYDRATING


WASH™


Benzoyl Peroxide in a Urea Vehicle


473 mL


DOAK DERMATOLOGICS










ZoDERM 
benzoyl peroxide hydrating wash  emulsion










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)10337-758
Route of AdministrationTOPICALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
benzoyl peroxide (benzoyl Peroxide)benzoyl peroxide57.5 mg  in 1 mL




























Inactive Ingredients
Ingredient NameStrength
water 
urea 
sodium lauryl sulfoacetate 
glycerin 
propylene glycol 
magnesium aluminum silicate 
cetyl alcohol 
glyceryl monostearate 
xanthan gum 
citric acid monohydrate 
sodium citrate 
edetate disodium 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
110337-758-51473 mL In 1 BOTTLE, PLASTICNone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved other10/09/2009


Labeler - PharmaDerm., A division of Nycomed US Inc. (043838424)

Registrant - Nycomed US Inc. (043838424)
Revised: 09/2009PharmaDerm., A division of Nycomed US Inc.




More ZoDERM resources


  • ZoDERM Side Effects (in more detail)
  • ZoDERM Use in Pregnancy & Breastfeeding
  • ZoDERM Drug Interactions
  • ZoDERM Support Group
  • 15 Reviews for ZoDERM - Add your own review/rating


  • ZoDerm Cleanser MedFacts Consumer Leaflet (Wolters Kluwer)

  • Zoderm Concise Consumer Information (Cerner Multum)

  • Zoderm Pads MedFacts Consumer Leaflet (Wolters Kluwer)



Compare ZoDERM with other medications


  • Acne
  • Perioral Dermatitis


No comments:

Post a Comment